Novavax, Inc.
NVAX
$10.64
$0.565.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.53M | -202.38M | 106.51M | 518.65M | -81.03M |
| Total Depreciation and Amortization | 5.13M | 6.59M | 7.56M | 8.34M | 12.52M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.58M | 137.67M | -1.20M | 27.11M | -56.00M |
| Change in Net Operating Assets | -73.70M | 165.93M | -240.33M | -739.60M | -48.65M |
| Cash from Operations | -39.48M | 107.80M | -127.46M | -185.50M | -173.16M |
| Capital Expenditure | -2.08M | -2.02M | -247.00K | -1.22M | -1.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 192.64M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.56M | -134.51M | 111.35M | -72.10M | -46.70M |
| Cash from Investing | 20.48M | -136.53M | 111.10M | -73.32M | 144.01M |
| Total Debt Issued | 0.00 | 42.61M | -- | -- | -- |
| Total Debt Repaid | -6.27M | -984.00K | -612.00K | -2.20M | -2.76M |
| Issuance of Common Stock | -- | 5.29M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -5.29M | -- | -666.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -330.00K | -4.47M | 4.86M | -4.86M | -- |
| Cash from Financing | -6.60M | 42.44M | -1.04M | -7.06M | -3.42M |
| Foreign Exchange rate Adjustments | -1.71M | 658.00K | 7.91M | -930.00K | -10.72M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.31M | 14.38M | -9.50M | -266.81M | -43.30M |